KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif

PLoS Pathogens

Volumn 7, Issue 3, 2011, Pages

  Colantonio, Arnaud D ^a   Bimber, Benjamin N ^b   Neidermyer Jr , William J ^a   Reeves, R Keith ^a   Alter, Galit ^c   Altfeld, Marcus ^c   Johnson, R Paul ^a,c   Carrington, Mary ^c,d   O'Connor, David H ^b   Evans, David T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TETRAMER; EPITOPE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA BW6; HLA-BW6; INWARDLY RECTIFYING POTASSIUM CHANNEL; MAMU A 01 ANTIGEN; MAMU-A 01 ANTIGEN; PEPTIDE;

ALLOTYPE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; GENETIC POLYMORPHISM; LYMPHOCYTE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION; VIRUS PATHOGENESIS; ANIMAL; GENETIC TRANSFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; LEUKEMIA CELL LINE; MACACA MULATTA; METABOLISM; MOLECULAR CLONING; PROTEIN CONFORMATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VIROLOGY;

MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CLONING, MOLECULAR; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; JURKAT CELLS; MACACA MULATTA; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN BINDING; PROTEIN CONFORMATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES; TRANSFECTION;

EID: 79953288896     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001316     Document Type: Article

References (64)

1. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
2. Parham P, (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5: 201-214.
3. Kim S, Sunwoo JB, Yang L, Choi T, Song Y-J, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A 105: 3053-3058.
4. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, et al. (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
5. Schwartz O, Marechal V, LeGall S, Lemonnier F, Heard J-M, (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338-342.
6. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
7. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, et al. (2010) Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A 107: 10160-10165.
8. Ayers J, Cresswell P, (1976) HLA-B specificities and w4, w6 specificities are on the same polypeptide. Eur J Immunol 6: 794-799.
9. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P, (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181: 1133-1144.
10. Mandelboim O, Wilson SB, Vales-Gomez M, Reyburn HT, Strominger JL, (1997) Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A 94: 5604-4609.
11. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, et al. (2007) Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178: 33-37.
12. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, et al. (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34: 1673-1679.
13. Rajagopalan S, Long EO, (1997) The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185: 1523-1528.
14. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE, (1997) Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A 94: 6313-6318.
15. Peruzzi M, Parker KC, Long EO, Malnati MS, (1996) Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157: 3350-3356.
16. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, et al. (1995) Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016-1018.
17. Fan QR, Long EO, Wiley DC, (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2: 452-460.
18. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD, (2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC. Nature 405: 537-543.
19. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740.
20. Martin MP, Gao X, Lee J-H, Nelson GW, Detels R, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434.
21. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
22. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, et al. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201: 1069-1075.
23. Chen C, Busson M, Rocha V, Appert M-L, Lepage V, et al. (2006) Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 38: 437-444.
24. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027-3036.
25. Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, et al. (1985) Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230: 71-73.
26. Boyson JE, Schufflebotham C, Cadavid LF, Urvater JA, Knapp LA, et al. (1996) The MHC class I genes of the rhesus monkey: Different evolutionary histories of the MHC class I and II genes in primates. J Immunol 156: 4656-4665.
27. Adams EJ, Parham P, (2001) Species-specific evolution of MHC class I genes in the higher primates. Immunol Rev 183: 41-64.
28. Hershberger KL, Shyam R, Miura A, Letvin NL, (2001) Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol 166: 4380-4390.
29. Bimber BN, Moreland AJ, Wiseman RW, Hughes AL, O'Connor DH, (2008) Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: Novel insights into nonhuman primate KIR gene content and organization. J Immunol 181: 6301-6308.
30. Sambrook JG, Bashirova A, Palmer S, Sims S, Trowsdale J, et al. (2005) Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res 15: 25-35.
31. Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE, (2010) The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics 62: 295-306.
32. Kruse PH, Rosner C, Walter L, (2010) Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics 62: 281-293.
33. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, et al. (2010) CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115: 4439-4446.
34. Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, et al. (2004) Idenification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 173: 5064-5076.
35. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, et al. (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 93: 12433-12438.
36. Anfossi N, Pasccal V, Vivier E, Ugolini S, (2001) Biology of T memory type 1 cells. Immunol Rev 181: 269-278.
37. Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, et al. (2009) Dimorphic motifs in D0 and D1 + D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 183: 4569-4582.
38. Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, et al. (2007) Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178: 647-651.
39. Khakoo SI, Geller R, Shin S, Jenkins JA, Parham P, (2002) The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J Exp Med 196: 911-921.
40. Parham P, (2006) Taking license with natural killer cell maturation and repertoire development. Immunol Rev 214: 155-160.
41. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, et al. (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166: 2992-3001.
42. Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, et al. (2002) Genetic control of human NK cell repertoire. J Immunol 169: 239-247.
43. Yawata M, Yawata N, Draghi M, Little A-M, Parheniou F, et al. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203: 633-645.
44. Alter G, Rihn S, Streeck H, Teigen N, Piechocka-Trocha A, et al. (2008) Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodefieciency virus type 1 infection. J Virol 82: 9668-9677.
45. Bonorino P, Leroy V, Dufeu-Duchesne T, Tongiani-Dashan S, Sturm N, et al. (2007) Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C. Hepatology 46: 1375-1386.
46. Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D, (1996) Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J Exp Med 183: 1817-1827.
47. Shimizu Y, Koller B, Geraghty D, Orr H, Shaw S, et al. (1986) Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells. Mol Cell Biol 6: 1074-1087.
48. Kaizu M, Borchardt GJ, Glidden CE, Fisk DL, Loffredo JT, et al. (2007) Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics 59: 693-703.
49. Raulet DH, Vance RE, McMahon CW, (2001) Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19: 291-330.
50. Pascal V, Stulberg MJ, Anderson SK, (2006) Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! Immunol Rev 214: 9-21.
51. Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, et al. (2007) Identification of bidirectional promoters in the human KIR genes. Genes Immun 8: 245-253.
52. Hoglund P, Brodin P, (2010) Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol 10: 724-734.
53. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song Y-J, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
54. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
55. Wiseman RW, Karl JA, Bimber BN, O'Leary CE, Lank SM, et al. (2009) Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med 15: 1322-1327.
56. Otting N, Heijmans CMC, Noort RC, de Groot NG, Doxiadis GG, et al. (2005) Unparalleled complexity of the MHC class I region in rhesus macaques. Proc Natl Acad Sci U S A 102: 1626-1631.
57. Mandelboim O, Reyburn HT, Valez-Gomez M, Pazmany L, Colonna M, et al. (1996) Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 184: 913-922.
58. Rajalingam R, Parham P, Abi-Rached L, (2004) Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol 172: 356-369.
59. DeGottardi MQ, Specht A, Metcalf B, Kaur A, Kirchhoff F, et al. (2008) Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol 82: 3139-3146.
60. Maria AD, Ferraris A, Guastella M, Pilia S, Cantoni C, et al. (1997) Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions. Proc Natl Acad Sci U S A 94: 10285-10288.
61. Bostik P, Kobkitjaroen J, Tang W, Villinger F, Pereira LE, et al. (2009) Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J Immunol 182: 3638-3649.
62. Anonymous, (1996) The Institute of Laboratory Animal Resources, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, D.C. National Academy Press pp. 86-123.
63. Robinson J, Mistry K, McWilliam H, Lopez R, Marsh SGE, (2010) IPD-the immuo polymorphism database. Nucleic Acids Res 38: D863-D869.
64. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, et al. (1996) The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184: 505-518.